Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Anticholinergic Syndrome MeSH Descriptor Data 2025


MeSH Heading
Anticholinergic Syndrome
Tree Number(s)
C25.100.311
Unique ID
D064807
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D064807
Scope Note
Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome.
Entry Term(s)
Central Anticholinergic Syndrome
Peripheral Anticholinergic Syndrome
Previous Indexing
Cholinergic Antagonists (1995-2013)
See Also
Cholinergic Antagonists
Public MeSH Note
2014
History Note
2014
Date Established
2014/01/01
Date of Entry
2013/07/08
Revision Date
2014/01/01
Anticholinergic Syndrome Preferred
Central Anticholinergic Syndrome Narrower
Peripheral Anticholinergic Syndrome Narrower
page delivered in 0.132s